The cellular content of phosphatidic acid can increase in response to several agonists either by phosphorylation of diacylglycerol after phospholipase C-catalyzed hydrolysis of phospholipids or 
T he hydrolysis of phosphatidylinositol 4,5-bisphos- phate (PIP2) by phospholipase C is an important pathway in hormone-regulated signal transduction in a variety of tissues. 1 The initial products of phospholipase C-mediated hydrolysis of PIP2, inositol 1,4,5-trisphosphate and diacylglycerol, mediate pivotal roles as intracellular second messengers through the mobilization of calcium from intracellular stores and activation of protein kinase C. 2, 3 Although the hydrolysis of PIP2 by phospholipase C and the intracellular effects of the second messengers have been studied extensively, little is known regarding the functional role of phosphatidic acid, which pholipase D by several agonists.67 Furthermore, phosphatidic acid generated via these pathways and subsequently released from the plasma membrane may exert secondary effects directly on other cell types.
Previous studies have suggested that intracellular phosphorylation of diacylglycerol to form phosphatidic acid may be the means whereby the cell controls the level of diacylglycerol. However, more recent studies have demonstrated the potential role for phosphatidic acid as a second messenger per se. [8] [9] [10] [11] [12] [13] [14] [15] These studies have implicated phosphatidic acid in the regulation of DNA synthesis,1"15 mobilization of intracellular calcium,1-14 stimulation of Na+-Ca`+ exchange,16 and induction of proto-oncogene expression." Several of the effects of phosphatidic acid have been shown to be associated with stimulation of the turnover of phosphoinositides,"1'-5 although the potential for phosphatidic acid to stimulate phospholipase C in cardiac cells has not been characterized previously. The mechanism of the phosphatidic acid effect is unknown, but phospha- tidic acid has been shown to stimulate in vitro activity of soluble and membrane-associated phospholipase C. 17 Accordingly, the purpose of the present study was to assess the influence of exogenous phosphatidic acid on phospholipase C in adult ventricular cardiac myocytes. The questions to be addressed included the following: 1) Does (10`4 M) in the corresponding HEPES buffers. The stock solutions were sonicated using a probe-type sonifier (Branson Ultrasonics Corp., Danbury, Conn.) until a homogeneous suspension was obtained. Contamination of phosphatidic acid with lysophosphatidic acid was assessed by thin-layer chromatography using short bed/continuous development (position 5, 60 minutes) and a solvent system of benzene/chloroform/pyridine/formic acid (60/ 38/4/2.3, by volume). The thin-layer chromatographic plates were stained with Coomassie blue R-250 and scanned with an LKB 2202-enhanced Ultrascan XL densitometer. The contamination of phosphatidic acid (ranging from 10 to 50 ,ug) with lysophosphatidic acid as calculated from a lysophosphatidic acid standard curve on the same plate was 1.26±0.12% (n=5) and less than 1.5% in sonicated phosphatidic acid stock solutions.
Aliquots (900 gl, =500,000 cells) of the cell suspension were incubated 10 minutes at 37°C in a water bath before adding 100 gl phosphatidic acid or vehicle (HEPES buffer). After a specified time interval, all incubations were terminated by addition of an equal volume of ice-cold 15% (wt/vol) trichloroacetic acid, vortexed for 15 seconds, and placed on ice for 10 minutes. The precipitate was removed by centrifugation, and the supernatant was decanted and placed into 16 x 125 -mm glass tubes coated with silane. Protein precipitate was resuspended in 1 ml distilled water and extracted with an equal volume of ice-cold trichloroacetic acid (15% [wt/vol]). The tubes were vortexed, the precipitate was sedimented by centrifugation, and the supernatants were decanted and combined with the corresponding supernatants from the first step. The trichloroacetic acid was removed by repetitive extraction with 3 ml H20-saturated diethyl ether. Residual ether was removed from the cell extract by lyophilizing the samples to dryness in a Speed-Vac centrifugal evaporator (Savant Instruments Inc., Farmingdale, N.Y.). The recovery of added ['H]IP3 after trichloroacetic acid extraction was greater than 95%.
Determination of Inositol Phosphates
The mass of inositol phosphates was measured using two different methods. Inositol 1,4,5-trisphosphate was determined by a binding assay using a specific and sensitive binding protein for inositol 1,4,5-trisphosphate. The assay is based on the competition between unlabeled inositol 1,4,5 -trisphosphate and a fixed quantity of ['H]inositol 1,4,5-trisphosphate for a limited number of binding sites on a bovine adrenal binding protein preparation. Lyophilized samples were resuspended in 1.5 ml distilled H20 and titrated to pH 7.5 with NaHCO3 (1 M) . Aliquots (100 ,ld) of the samples were then assayed directly using a D-myo-inositol 1 A characteristic feature of agonist-induced PIP2 hydrolysis is the rapid and transient accumulation of 1P3, which is phosphorylated to 1P4 and a more gradual and sustained accumulation of 1P2 and IP1. Therefore, inositol phosphate metabolites were measured in rabbit myocytes exposed to phosphatidic acid for selected time intervals (Figure 2) . Stimulation of the cells with phosphatidic acid (1 uM) resulted in a rapid increase in the total mass of IP3, which was followed with a delay of approximately 15 (1 mM) and then stimulated with phosphatidic acid (1 ,uM) . The increase in inositol 1,4,5-trisphosphate after 20 seconds of stimulation with phosphatidic acid was not altered in the absence of extracellular calcium, even in the presence of EGTA (Figure 4) . Although the basal levels of inositol 1,4,5-trisphosphate in cells were slightly but not significantly lower in the absence of extracellular Ca2+, the response of the myocytes to stimulation with phosphatidic acid was comparable to that seen in the presence of extracellular calcium. Discussion This is the first report demonstrating that phosphatidic acid stimulates inositol phosphate production in adult cardiac myocytes, leading to a marked increase in (10`6 M) platelet-associated phospholipase C, indicating that phosphatidic acid may interact directly with the enzyme or alter the lipid environment of the substrate to increase susceptibility to phospholipase C attack.17 Alternatively, phosphatidic acid has been shown to stimulate phosphatidylinositol-4-phosphate kinase activity.25 Activation of this enzyme may result in a faster replenishment of the PIP2 pool accessible for enzymatic breakdown by phospholipase C. An additional possibility, suggested by Murayama and Ui,8 is that phosphatidic acid may interact with a specific membrane receptor, thereby triggering multiple effector systems including inhibition of adenylyl cyclase and activation of phospholipase C. This hypothesis is based on the finding that the ability of exogenous phosphatidic acid to inhibit adenylyl cyclase activity in 3T3 fibroblasts is GTP dependent, sensitive to inactivation by pertussis toxin, and blocked by antagonists of phosphatidic acid. This hypothesis requires additional support, since exogenous phosphatidic acid may in fact gain access to intracellular phospholipase C, which involves formation of diacylglycerol at the plasma membrane, transbilayer movement of diacylglycerol, and intracellular rephosphorylation to phosphatidic acid. 26 Regardless of the mechanism whereby phosphatidic acid regulates the activity of phospholipase C, the ability of phosphatidic acid to stimulate the production of the second messengers inositol 1,4,5-trisphosphate and, presumably, diacylglycerol in adult cardiac ventricular myocytes is likely to have very important implications for cell function. First, the ability of exogenous phosphatidic acid to activate phospholipase C accounts for the biological effects of this phospholipid that mimic the responses evoked by hormones known to stimulate phospholipase C. Although release of phosphatidic acid from platelets has been shown on stimulation with thrombin,8 further studies are required to establish a role for phosphatidic acid as an extracellular regulator of cardiac cell function. A second possible role for phosphatidic acid may be linked to intracellular production of phosphatidic acid from diacylglycerol via phosphorylation after hormone activation of phospholipase C. Newly formed phosphatidic acid could then enhance the turnover of PIP2 through intracellular activation of phospholipase C, providing a positive feedback mechanism that could sustain a hormonal response. This, however, remains to be established. Further studies will be required to assess which specific subform(s) of phospholipase C is activated by phosphatidic acid or whether the effect is ubiquitous for all subforms of the enzyme.27 Third, agonist-induced activation of phospholipase D to yield phosphatidic acid directly may serve as an alternative pathway by which receptor agonists could activate phospholipase C-mediated cleavage of PIP2. Potential hormones for such an alternative pathway are growth factors, muscarinic and aladrenergic agonists, and endothelin, which have been shown to activate both phospholipase D-catalyzed production of phosphatidic acid and formation of IP3.6,7,21,28 ' 3 Fourth, phosphatidic acid production within the sarcolemma of cardiac myocytes might result from the action of an extracellular phospholipase D. Such humoral phospholipase D activity has been detected in human plasma. 34 The effects of exogenously applied phospholipase D have been investigated in isolated tissues and subcellular fractions. For example, exogenous phospholipase D increased the contractility of neonatal rat ventricular tissue35 and produced positive inotropy in rabbit papillary muscle. 36 Philipson and Nishimoto'6 demonstrated that exogenous phospholipase D stimulated Na+-Ca2' exchange in cardiac sarcolemmal vesicles, which was accompanied by an increase of phosphatidic acid in the sarcolemma. Depending on the intracellular and extracellular Na+ and Ca21 concentrations and the membrane potential, this bidirectional transport mechanism could elevate cytosolic calcium and thereby increase contractility. In view of the findings in the present study, stimulation of phospholipase C may be another important mechanism by which phosphatidic acid could increase myocardial contractility. Inositol In summary, the present study has clearly demonstrated that phosphatidic acid is a potent activator of cardiac inositol phosphate production. Future studies pertaining to the functional significance of this novel mechanism will be required. It is evident, however, that phosphatidic acid may serve a key regulatory role in potentiating the phospholipase C-mediated generation of intracellular second messengers involved in regulation of cardiac cells.
